Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 12 a 30 di 30
Titolo Data di pubblicazione Autori Tipo File Abstract
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab : A Secondary Analysis of the HERA Trial 2016 G. Viale + Article (author) -
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial 2023 Veronesi, PaoloViale, GiuseppeLazzeroni, MatteoJohansson, Harriet + Article (author) -
Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial 2021 Curigliano G. + Article (author) -
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial. 2018 Siena S. + Article (author) -
Expert Review of Breast Pathology in Borderline Lesions : a Chance to Reduce Overdiagnosis and Overtreatment? 2018 Sardanelli, FrancescoTrimboli, Rubina M. + Article (author) -
The genomic grade assay compared with Ki67 to determine risk of distant breast cancer recurrence 2016 G. Viale + Article (author) -
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019 2023 La Vecchia, Carlo + Article (author) -
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017. A Systematic Analysis for the Global Burden of Disease Study 2019 Damiani G.La Vecchia C. + Article (author) -
Hereditary Diffuse Gastric Cancer Syndrome : CDH1 Mutations and Beyond 2015 Corso Giovanni + Article (author) -
Human epidermal growth factor receptor 2 as amolecular biomarker formetastatic colorectal cancer 2018 A. Sartore-BianchiS. Siena + Article (author) -
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review 2021 Curigliano G. + Article (author) -
Magnetic Resonance Imaging-Based Prediction of Prostate Cancer Risk 2018 Rocco, Bernardo + Article (author) -
Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas after Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT 2019 Corradini, Paolo + Article (author) -
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 2019 Pietrantonio, FilippoRaimondi, AlessandraSartore-Bianchi, AndreaNiger, MonicaPetrelli, FaustoLongarini, RaffaellaDi Bartolomeo, Mariade Braud, Filippo + Article (author) -
Molecular markers beyond microsatellite instability for assessing prognosis in early-stage colorectal cancer: What happens at relapse? 2017 Sartore-Bianchi A. Article (author) -
Moving from Cancer Burden to Cancer Genomics for Smoldering Myeloma : a Review 2019 Maura F.Bolli N. + Article (author) -
Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 2019 Pietrantonio, Filippo + Article (author) -
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review 2019 Curigliano G. + Article (author) -
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination with Nivolumab for Patients with Advanced Solid Tumors : A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial 2020 Curigliano G. + Article (author) -
Mostrati risultati da 12 a 30 di 30
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile